Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state.
about
Current challenges and novel treatment strategies in double hit lymphomasFunctional Significance of Aurora Kinases-p53 Protein Family Interactions in CancerDrugging the addict: non-oncogene addiction as a target for cancer therapyTranscriptional control of mitosis: deregulation and cancerChk2 deficiency in Myc overexpressing lymphoma cells elicits a synergistic lethal response in combination with PARP inhibitionInhibition of Aurora kinase B is important for biologic activity of the dual inhibitors of BCR-ABL and Aurora kinases R763/AS703569 and PHA-739358 in BCR-ABL transformed cellsSelective Targeting of CTNBB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing DrugsInhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumorsSMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancersMYC on the path to cancerAndrogen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulationPhase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomasPhase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108.Three steps to the immortality of cancer cells: senescence, polyploidy and self-renewal.Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer.Aurora kinases: novel therapy targets in cancersTargeting high Aurora kinases expression as an innovative therapy for hepatocellular carcinoma.SIX3, a tumor suppressor, inhibits astrocytoma tumorigenesis by transcriptional repression of AURKA/B.Comparison of selected gene expression profiles in sensitive and resistant cancer cells treated with doxorubicin and SelolSmall cell lung cancer: where do we go from here?The ARF tumor suppressor prevents chromosomal instability and ensures mitotic checkpoint fidelity through regulation of Aurora B.Cks1 is required for tumor cell proliferation but not sufficient to induce hematopoietic malignanciesMyc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.Visual gene-network analysis reveals the cancer gene co-expression in human endometrial cancerUpdate on aurora kinase inhibitors in gynecologic malignancies.Targeting the MYC and PI3K pathways eliminates leukemia-initiating cells in T-cell acute lymphoblastic leukemiaMelanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions.Bmi1 drives stem-like properties and is associated with migration, invasion, and poor prognosis in tongue squamous cell carcinoma.Update on Aurora Kinase Targeted Therapeutics in Oncology.GP130 activation induces myeloma and collaborates with MYC.Alisertib added to rituximab and vincristine is synthetic lethal and potentially curative in mice with aggressive DLBCL co-overexpressing MYC and BCL2.Site-specific programming of the host epithelial transcriptome by the gut microbiotaMechanism of action and therapeutic efficacy of Aurora kinase B inhibition in MYC overexpressing medulloblastoma.Aurora kinase inhibition overcomes cetuximab resistance in squamous cell cancer of the head and neckCombined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer models.Direct and indirect targeting of MYC to treat acute myeloid leukemiaSmall cell lung cancer: will recent progress lead to improved outcomes?Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas.MYC Is a Major Determinant of Mitotic Cell Fate.Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation.
P2860
Q26770385-76076059-73EB-4C96-8A34-1E4292135A49Q28071615-9D5EE0EB-D4AB-4372-95B0-AD9F177DCBFEQ28079559-536C64E0-EC15-4477-BC9A-1FF208C9C694Q28082114-F7CE1F97-4011-4BC7-9875-04689C0551C3Q28396027-42DAE1E8-6AA0-4141-8893-978E7AA8850CQ28545195-DCA04A03-284A-4D68-8F7B-8E3ACC3CA7B8Q28547522-A16BFF89-1ADD-4FF0-8D32-E3C6647D3705Q28817295-9090D1A2-C53A-4003-844C-356C7E347205Q28818608-91F1EB7B-C640-4AF8-ACB3-6A3DB2A2707AQ29619979-8EB2CF36-58C8-494F-8AD9-B7B37060A42AQ33390573-BDB07723-BE96-45CE-857F-A01B1F1C404FQ33410380-9FB032D4-74CF-4C34-82F0-7BB1F7EE1424Q33423638-721EF730-9785-420C-8F8F-00CDA2F7E95AQ33590178-D00FB97C-D8AD-4B9B-8357-6A9E2E462946Q33604452-C40912E3-A4B9-4C23-8713-6F9E29D82EEDQ33618929-97B8A5D8-C747-4CD0-91BE-44C321BA1AA4Q33709521-F1CD88E1-9DF7-4E76-B7F6-4D4D9D50A482Q33781657-91B88E2E-EC7C-4A29-89DB-10E8EF7EA64AQ33799201-55DE6869-FD3E-4CEF-83A7-F9C11566A0E7Q33872327-C995C2A7-CA03-4F97-94E3-EC3853F93CB3Q34166850-288C1111-690A-45DB-9289-7AE3A9DA52A0Q34279980-33ACBAE5-69D8-4512-A40B-6C033F0715B7Q34293007-FC6C62D5-FCFA-49EB-A9F8-B02C52234917Q34525508-4CA19B36-CAD7-4981-8B5A-AA2AADF71A14Q34576017-6305183B-21AA-4354-8E8B-6A81DAABE8E1Q34645214-AB1CBBE7-722C-460B-9762-0B44A06B53E4Q34654508-179EBD54-6447-4FE2-91B2-238864D7775EQ34780881-F2306E4A-9FB6-41BB-87A8-8C504E6EA9BEQ34941504-324310D8-D97E-47A2-ADE9-7C4131EA711CQ35145350-0D78962E-221D-4DFF-BAF8-3BC61C442E78Q35180822-9297B615-294B-4D90-9BC5-B2850744CF5DQ35500118-C6C25EB3-6553-4373-85C2-AEC276EA5892Q35550246-7CA5225D-61EA-4368-BE6A-F7252C2E4A88Q35640310-2AA1C021-4F23-4391-8586-05BBBF4692B1Q35745893-84F47031-0489-4838-ACAD-3F7560E75966Q35798798-9B121FD6-5BFE-4CCB-B8BE-BE590FF1F226Q35836257-09E85801-3AF3-48CB-82EB-46980478A20EQ35859974-CD9D4592-E22F-4BDA-9DA9-26FD5DCB9CE0Q35898987-0D11D04A-3A5F-4FFD-8837-09C26397044FQ35954892-4F3DF5E1-FB58-4CCB-82A5-933E34D7875A
P2860
Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Aurora kinases A and B are up- ...... enance of the malignant state.
@ast
Aurora kinases A and B are up- ...... enance of the malignant state.
@en
Aurora kinases A and B are up- ...... enance of the malignant state.
@nl
type
label
Aurora kinases A and B are up- ...... enance of the malignant state.
@ast
Aurora kinases A and B are up- ...... enance of the malignant state.
@en
Aurora kinases A and B are up- ...... enance of the malignant state.
@nl
prefLabel
Aurora kinases A and B are up- ...... enance of the malignant state.
@ast
Aurora kinases A and B are up- ...... enance of the malignant state.
@en
Aurora kinases A and B are up- ...... enance of the malignant state.
@nl
P2093
P2860
P1433
P1476
Aurora kinases A and B are up- ...... tenance of the malignant state
@en
P2093
Alexander Hoellein
Andrei Goga
Christian Peschel
John L Cleveland
Jonas A Nilsson
Justus Duyster
Jürgen den Hollander
Marcus Kremer
Mark A Hall
Markus Scheerer
P2860
P304
P356
10.1182/BLOOD-2009-11-251074
P407
P577
2010-06-02T00:00:00Z